FEM Q3 2024 Manager Letter

The strategy focuses on investing in frontier and emerging market companies that our team expects will benefit from demographic trends, changing consumer behaviour, policy and regulatory reform and technological advancements.

Below, we explore several key factors influencing returns and share observations on the portfolio and the markets.

Internet and technology portfolio

Investments that we wrote about in previous letters, including Lithuania’s Baltic Classifieds Group (BCG) and Egypt’s Fawry for Banking Technology and E-Payments (Fawry), performed well in the quarter.

BCG is the leading online classifieds group in the Baltics with a dominant position in auto, real estate, jobs and services and generalist marketplaces in Lithuania and Estonia. The company’s shares rallied in the quarter as the market reacted positively to the exit of Apax Partners LLP, the private equity firm that brought BCG to market via IPO in July 2021. Private equity ownership of public companies can often lead to an overhang on the share price and liquidity in the market. Typically, incremental buyers are discouraged by the prospect of an eventual wall of shares hitting the market when the private equity owner(s) decides to sell, and liquidity is lower because a relatively large percentage of the outstanding shares is not freely floated. A high-quality business like BCG, whose revenues and operating profits grew approximately14% annually over the last 4 years, generally absorb this type of overhang on their shares as incremental buyers step into liquidity events with more confidence. This was the mindset with which we approached BCG and thus actively participated in Apax Partners’ share sales this year, ramping up our participation as they approached their exit sale in July.

Fawry is the leading payments technology company in Egypt. The business is anchored by a base of over 360k point of sale machines (POS) that enable merchants to accept payments for the sale of their own merchandise (e.g.: a carbonated beverage) or on behalf of other large businesses like telecoms and utilities. Fawry has leveraged its first mover advantage in POS by introducing value-added services to their merchants such as supply chain financing (i.e.: working capital loans), ATM (a consumer can take out cash from a POS using the merchant’s float at the till for a fee), payment acceptance across many services and agency banking where it acts as a distributor of bank products to underbanked merchants and consumers through dedicated branches that are branded FawryPlus.

Fawry’s merchant offering extends beyond brick and mortar; it is also a leading payment gateway enabling online payments between consumers and merchants and, in the process, captures a piece of the fast-growing e-commerce market in Egypt. On the consumer side, Fawry’s app (MyFawry) counts over 5 million downloads and is experiencing strong momentum, driven by the introduction of a wide range of use cases including bill payments, virtual debit card wallets, buy-now-pay-later, insurance and savings products. In an inflationary environment like Egypt’s, Fawry’s transaction-based revenue model means it can grow revenues at a faster rate than costs due to the operating leverage inherent in its business. This was evident in second quarter 2024 results with operating margins expanding by more than 6% compared to the same period last year. Fawry shares reacted positively to the results, and more importantly to management guidance on net income for the full year, which implied a growth of about 67% y-o-y in local currency.

Like BCG, Fawry shares also benefited from the exit of private equity firm Helios Investment Partners (Helios) from the company in the quarter. Helios has been pressuring the shares through open market sales. Like the BCG case, we took advantage of the liquidity event and were involved in a discounted clean-up sale in which Helios sold its remaining 5% stake in Fawry, which helped remove the overhang on the shares.

Healthcare portfolio

The strategy experienced good returns from the healthcare portfolio during the quarter, driven mainly by Morocco’s Aktidal Group (AKT).

AKT is the leading healthcare provider in the country with approximately 15% of the private bed capacity in the country. The Moroccan healthcare market is severely underserved, with the rates of beds and physicians per 1,000 persons below regional averages and well below WHO recommended levels. (A WHO study ranks Morocco 79th of 115 countries in doctors per capita.) This has severely curtailed investment in the sector, with private providers accounting for under 30% of bed capacity in the country of around 40 million people. To address this shortage, the Moroccan government embarked on a series of reforms including rolling out a universal healthcare scheme and removing a restriction that allowed only doctors to invest in the sector. AKT operates 2,532 beds in 23 sites spread across 11 cities.

The clinics managed by AKT are known for their quality of care and the strength of their oncology department (30% of consolidated revenue). AKT is at the forefront of the growth in the sector: its 2023 results which showed revenue and operating profit growth of 84% and 86% respectively. On a recent trip to Morocco, we conducted site visits and meetings with Moroccan doctors and competitors of AKT which validated the company’s brand and reputation in the market and highlighted the growth opportunity that lies ahead for the company.

Outlook

We continue to be constructive on the opportunity set for the strategy as we enter the fourth quarter of the year. We believe we positioned the portfolio to be considerate of changes in the interest rate cycle, political environment and portfolio company valuations. As always, the ultimate objective of our decision-making process is to express our best research opinions through a diversified portfolio of high-quality businesses that we believe will help us deliver on the strategy’s return objective.

We look forward to continuing to update you on the strategy over the rest of the year.